AU3057797A - Antibacterial agents - Google Patents
Antibacterial agentsInfo
- Publication number
- AU3057797A AU3057797A AU30577/97A AU3057797A AU3057797A AU 3057797 A AU3057797 A AU 3057797A AU 30577/97 A AU30577/97 A AU 30577/97A AU 3057797 A AU3057797 A AU 3057797A AU 3057797 A AU3057797 A AU 3057797A
- Authority
- AU
- Australia
- Prior art keywords
- antibacterial agents
- antibacterial
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
- C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1678996P | 1996-05-07 | 1996-05-07 | |
US60016789 | 1996-05-07 | ||
PCT/US1997/007455 WO1997042179A1 (en) | 1996-05-07 | 1997-05-02 | Antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3057797A true AU3057797A (en) | 1997-11-26 |
Family
ID=21778992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30577/97A Abandoned AU3057797A (en) | 1996-05-07 | 1997-05-02 | Antibacterial agents |
Country Status (3)
Country | Link |
---|---|
US (1) | US5925659A (en) |
AU (1) | AU3057797A (en) |
WO (1) | WO1997042179A1 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1143951A3 (en) * | 1998-09-21 | 2002-02-06 | University Of Florida Research Foundation, Inc. | Antimalarial agents |
EP1488791A3 (en) * | 1998-09-21 | 2005-04-06 | University Of Florida Research Foundation, Inc. | Antimalarial agents |
US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
GB9914255D0 (en) * | 1999-06-18 | 1999-08-18 | Lilly Forschung Gmbh | Pharmaceutical compounds |
PT1251848E (en) * | 2000-01-18 | 2004-10-29 | Vertex Pharma | GELASE INHIBITORS AND THEIR UTILIZATIONS |
US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
US20050124021A1 (en) * | 2000-06-14 | 2005-06-09 | Newton Gerald L. | Acetyl glucosaminyl inositol deacetylase, a mycothiol biosynthetic enzyme, and methods of use |
DE60239316D1 (en) * | 2001-01-16 | 2011-04-14 | Univ Ramot | HYBRID PEPTIDES FOR THE TREATMENT OF BACTERAEMY AND SEPSIS |
CA2492035A1 (en) * | 2002-07-11 | 2004-01-15 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
EA011808B1 (en) * | 2003-01-08 | 2009-06-30 | Новартис Вэксинес Энд Дайэгностикс, Инк. | Antibacterial agents |
US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
EP2338878A3 (en) | 2005-12-15 | 2011-11-16 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
WO2008027466A1 (en) | 2006-08-31 | 2008-03-06 | Schering Corporation | Hydantoin derivatives useful as antibacterial agents |
CN107021895A (en) * | 2007-06-12 | 2017-08-08 | 尔察祯有限公司 | Antiseptic |
WO2009158369A1 (en) | 2008-06-25 | 2009-12-30 | Schering Corporation | Synthesis and use of heterocyclic antibacterial agents |
AU2009279949A1 (en) * | 2008-08-04 | 2010-02-11 | Merck Sharp & Dohme Corp. | Urea derivatives as antibacterial agents |
WO2010024356A1 (en) * | 2008-08-27 | 2010-03-04 | 大正製薬株式会社 | Novel hydroxamic acid derivative having naphthyridine-n-oxide |
WO2010100475A1 (en) * | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Hydroxamic acid derivatives as gram-negative antibacterial agents |
WO2011005355A1 (en) * | 2009-05-07 | 2011-01-13 | Achaogen, Inc. | Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria |
WO2012031298A2 (en) | 2010-09-03 | 2012-03-08 | Duke University | Ethynylbenzene derivatives |
AR083760A1 (en) | 2010-11-10 | 2013-03-20 | Achaogen Inc | ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS |
EP2847168A1 (en) | 2012-05-10 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
KR101946107B1 (en) * | 2012-08-25 | 2019-02-08 | 욱크하르트 리미티드 | 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
WO2014165075A1 (en) | 2013-03-12 | 2014-10-09 | Achaogen, Inc. | Antibacterial agents |
US10647664B2 (en) | 2013-08-16 | 2020-05-12 | Duke University | Substituted hydroxamic acid compounds |
WO2015024021A2 (en) | 2013-08-16 | 2015-02-19 | Duke University | Antibacterial compounds |
US9908851B2 (en) | 2013-08-16 | 2018-03-06 | Duke University | 2-piperidinyl substituted N,3-dihydroxybutanamides |
CN103923029B (en) * | 2014-03-13 | 2016-03-09 | 吴文君 | A kind of dihydro-oxazole class microbiotic and preparation method thereof |
CN104817512B (en) * | 2015-05-04 | 2016-09-21 | 吉林百年汉克制药有限公司 | A kind of synthetic method of oxazolines pharmaceutical intermediate compound |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2714082A (en) * | 1955-07-26 | New oxazoline derivatives | ||
US2772281A (en) * | 1954-12-23 | 1956-11-27 | Merck & Co Inc | Synthesis of 4-amino-3-isoxazolidone and its derivatives |
US2840565A (en) * | 1954-12-23 | 1958-06-24 | Merck & Co Inc | Optical isomers of 4-amino-3-isoxazolidone |
US3709992A (en) * | 1966-12-07 | 1973-01-09 | Us Rubber Co | Fungicidal use of certain carboxamidothiazoles |
DE1642005A1 (en) * | 1967-07-20 | 1971-04-29 | Dynamit Nobel Ag | Use of new cyclic N-S compounds as bacterostatics and fungistats |
US4061749A (en) * | 1976-07-06 | 1977-12-06 | Shell Oil Company | 5,6-Dihydro-4H-1,3-thiazine-2-carboxaldehyde oxime useful as insecticides |
US4565654A (en) * | 1983-03-28 | 1986-01-21 | University Of Notre Dame Du Lac | N-Acyloxy monocyclic β-lactams |
US5283275A (en) * | 1990-06-28 | 1994-02-01 | Becton, Dickinson And Company | Clarifiers for polyolefins and polyolefin compositions containing same |
-
1997
- 1997-04-25 US US08/845,291 patent/US5925659A/en not_active Expired - Fee Related
- 1997-05-02 AU AU30577/97A patent/AU3057797A/en not_active Abandoned
- 1997-05-02 WO PCT/US1997/007455 patent/WO1997042179A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US5925659A (en) | 1999-07-20 |
WO1997042179A1 (en) | 1997-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3057797A (en) | Antibacterial agents | |
AU690054B2 (en) | Earmuff-eyeglass combination | |
AU2784397A (en) | Contrast agents | |
AU4040197A (en) | Microturbomachinery | |
AU3387997A (en) | Autonotification | |
AU2845197A (en) | Cycloalkano-pyridines | |
AU4013397A (en) | Arylalkanoylpyridazines | |
AU4176997A (en) | 3-alkyl-3-phenyl-piperidines | |
AU2684197A (en) | Handleset | |
AU4218597A (en) | Superseat | |
AU3499397A (en) | Antibacterial composition | |
AU3701397A (en) | Anti-herpesviral agent | |
AU2090897A (en) | Hydroxyhexahydropyridazines | |
AU3620297A (en) | Substituted triazoloazinesulphonamides | |
AU3581497A (en) | Novel antibacterial compounds | |
AU3130597A (en) | Tristetraprolin | |
AU3307399A (en) | Novel antibacterial agents | |
AU3554995A (en) | Antipicornaviral agents | |
AU3771497A (en) | Substituted p-trifluoromethylphenyluracils | |
AU1926397A (en) | Substituted 1-methyl-3-benzyluracils | |
AU2237197A (en) | Fishing-lure | |
AU4332497A (en) | Endo-beta-galactosidase | |
AU1900097A (en) | Cremators | |
AU2955597A (en) | Substituted phenyluracils | |
AU3557397A (en) | Double-tau-profile |